In our study, analysis of 64 clinical patient samples of HCC revealed that 43.8% of patients exhibited NQO1 overexpression, and the majority of patients showed low CAT levels in tumors compared with adjacent normal tissues. Here, NQO1 is linked to hepatocellular carcinoma.